Integra Lifesciences Holdings Corp (NAS:IART)
$ 25.99 0.69 (2.73%) Market Cap: 2.05 Bil Enterprise Value: 1.55 Bil PE Ratio: 51.98 PB Ratio: 0.71 GF Score: 81/100

Q3 2022 Integra Lifesciences Holdings Corp Earnings Call Transcript

Oct 26, 2022 / 12:30PM GMT
Release Date Price: $47.21 (+5.85%)
Operator

Hello, and welcome to the Integra LifeSciences Third Quarter 2022 Financial Results. My name is Caroline, and I will be your coordinator for today's event. Please note, this call is being recorded. (Operator Instructions) I will now hand over the call to your host, Chris Ward, Senior Director, Investor Relations, to begin today's conference. Thank you.

Chris Ward

Thank you, Caroline. Good morning, and thank you for joining the Integra LifeSciences Third Quarter 2022 Earnings Conference Call. Joining me on the call are Jan De Witte, President and Chief Executive Officer; Carrie Anderson, Chief Financial Officer.

Earlier today, we issued a press release announcing our third quarter 2022 financial results. The release and corresponding earnings presentation, which we will feature during the call, are available at integralife.com under Investors, Events and Presentations and a file named Third Quarter 2022 Earnings Call Presentation.

Before we begin, I would like to remind you that many of the statements made during this call may be considered forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot